Analyze the genes of each tumor
The result of the joint work of the AstraZeneca biopharmaceutical company and the N.N.Petrov Research Institute of Oncology will be a project for the diagnosis of gene mutations in tumor samples, with the help of which it will be possible to more accurately select drugs for the treatment of a number of oncological diseases.
14.02.2013